Law360, New York (May 22, 2007, 12:00 AM EDT) -- Fresenius Medical Care has lashed out at Baxter International Inc. for arguing against Fresenius’ bid to stay a second damages trial in a longstanding legal feud involving patents related to hemodialysis machines.
The medical device maker said in court documents filed Tuesday in the U.S. District Court for the Northern District of California that to proceed to a damages trial would be “a wasted exercise” because there is a strong likelihood that expected rulings by the U.S. Patent Office and the U.S. Court of Appeals for...
Fresenius Renews Bid To Stay Damages Trial
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
